Pfizer Inc
Stocks making the biggest moves midday: VF Corporation, Pfizer, F5, JetBlue and more
Check out the companies making headlines in midday trading: VF Corporation — Shares jumped more than 22%. The North Face and JanSport parent’s quarterly results beat Wall Street’s expectations for the fiscal second quarter. VF Corporation posted adjusted earnings of 60 cents per share on revenue of $2.76 billion. That is above the 37 cents […]
Read More
Stocks making the biggest moves premarket: VF Corp, McDonald’s, Pfizer, PayPal and more
Check out the companies making headlines before the bell. VF Corp – Shares soared nearly 20% following the North Face and JanSport parent’s better-than-expected quarterly results. For the fiscal second quarter, the company posted adjusted earnings of 60 cents per share on $2.76 billion in revenue. Analysts surveyed by LSEG were looking for 37 cents […]
Read More
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
Kena Betancur | Corbis News | Getty Images Pfizer on Tuesday reported third-quarter revenue and adjusted profit that blew past expectations as the company’s Covid vaccine and antiviral pill Paxlovid helped boost sales. The pharmaceutical giant also hiked its full-year outlook and now expects to book adjusted earnings per share of $2.75 to $2.95, up […]
Read More
Stock futures are little changed as Wall Street awaits labor data and more earnings: Live updates
Traders work on the floor of the New York Stock Exchange during morning trading in New York City. Michael M. Santiago | Getty Images Stock futures are muted Monday night as investors readied for employment data and closely followed corporate earnings releases. Dow Jones Industrial Average futures added just 13 points, sitting slightly above flat. […]
Read More
Wall Street braces for a big week ahead of the election, with megacap tech earnings, key data on tap
Wall Street is about to get hit with the newsiest week yet ahead of the election — just as the stock market has started to falter. Investors will contend with earnings results from five of the Magnificent Seven companies next week. Alphabet’s results are set to be released Tuesday. Microsoft and Meta Platforms post their […]
Read More
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021. Andrew Kelly | Reuters Merck on Thursday said its experimental treatment designed to protect infants from respiratory syncytial virus showed positive results in a mid- to late-stage trial, bringing the company one step closer to filing […]
Read More
Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Wednesday said the Food and Drug Administration has put a hold on its application for a combination […]
Read More
Pfizer threatened to sue renegade executives prior to activist schism, Starboard’s Smith says
Ian Read, chairman and chief executive officer of Pfizer Inc., gestures as he speaks during a panel session at the World Economic Forum (WEF) in Davos, Switzerland, on Tuesday, Jan. 17, 2017. Simon Dawson | Bloomberg | Getty Images Activist Starboard Value accused Pfizer of threatening litigation against the company’s former CEO and CFO in […]
Read More
Former Pfizer CEO, finance chief step back from Starboard’s activist campaign
Ian Read, chairman and chief executive officer of Pfizer, speaks as President Donald Trump, left, listens during an announcement on a new pharmaceutical glass packaging initiative in the Roosevelt Room of the White House in Washington, D.C., July 20, 2017. Andrew Harrer | Bloomberg | Getty Images Former Pfizer CEO Ian Read and ex-CFO Frank […]
Read More
Healthy Returns: What activist Starboard’s $1 billion stake means for Pfizer
Jakub Porzycki | Nurphoto | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Happy Tuesday! Pfizer‘s troubles may finally be coming to a head. Former executives of the pharmaceutical giant are backing a […]
Read More